The impact of portal vein tumor thrombosis on survival in patients with hepatocellular carcinoma treated with different therapies: A cohort study.
Aline Mähringer-KunzVerena SteinleRoman KloecknerSebastian SchottenFelix HahnIrene SchmidtmannJan Bernd HinrichsChristoph DüberPeter Robert GalleHauke LangArndt WeinmannPublished in: PloS one (2021)
Treatment strategy for HCC with PVTT should not be limited to systemic therapy in general. The extent of PVTT should be considered when deciding on treatment alternatives. In patients with segmental PVTT (Vp1), resection should be evaluated.